Home » Authors » Jim Shrine

Jim Shrine

Articles

ARTICLES

Celldex Starts Phase II/III Trial Of Peptide Vaccine In Brain Cancer

May 25, 2007

NewCo News: Arete Completes $51M Round For New Hypertension Class

May 24, 2007

Genomic Health raises $46.5M to push personalized medicine

May 24, 2007

Phase Forward offering at $90M; Genomic Health raises $45 million

May 24, 2007

NewCo News: Arete Completes $51M Round For New Hypertension Class

May 24, 2007

Genomic Health Raises $46.5M For Personalized Diagnostics

May 23, 2007

Genomic Health Raises $46.5M For Personalized Diagnostics

May 23, 2007

Eurand Raises $112M In IPO For Internal, Collaborative Programs

May 18, 2007

Eurand Raises $112M In IPO For Internal, Collaborative Programs

May 18, 2007

Marcadia Raises $15M In First Round For Metabolic Programs

May 16, 2007

View All Articles by Jim Shrine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...